+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nonvalvular Atrial Fibrillation and Diabetic Nephropathy: Epidemiology, Prognosis, and Choice of Anticoagulant Therapy



Nonvalvular Atrial Fibrillation and Diabetic Nephropathy: Epidemiology, Prognosis, and Choice of Anticoagulant Therapy



Kardiologiia 58(4): 81-95



In this review we present data on prevalence of atrial fibrillation (AF) among patients with type 2 diabetes (T2D), diabetic nephropathy and chronic kidney disease (CKD). Patients with nonvalvular AF and T2D combined with CKD have elevated risk of both bleeding and thromboembolic complications, as well as of all cause death. Efficacy and safety of novel oral anticoagulants (NOAC) depend on comorbidities and can be determined by the presence of T2D and/or diabetic nephropathy. Use of warfarin in CKD in some cases provides no preventive effect relative to risk of stroke and is characterized by increased risk of bleeding because of poor INR control, and possibly development of calcification of arteries. Presence of diabetic nephropathy requires monitoring of renal filtration function for correction of doses or selection of another anticoagulant. Lack of data from randomized controlled trials hampers choice of anticoagulant therapy in patients with terminal CKD on hemodialysis or after renal transplantation.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 066446495

Download citation: RISBibTeXText

PMID: 30704390


Related references

Nonvalvular Atrial Fibrillation and Diabetic Nephropathy: Epidemiology, Prognosis, and Choice of Anticoagulant Therapy. Kardiologiia 2018(4): 81-95, 2018

Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circulation. Cardiovascular Quality and Outcomes 8(2 Suppl 1): S12-S20, 2015

Physician's fear of anticoagulant therapy in nonvalvular atrial fibrillation. American Journal of the Medical Sciences 348(6): 513-521, 2015

Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. International Journal of Stroke 10(6): 836-842, 2016

Underusage of anticoagulant therapy in nonvalvular atrial fibrillation Analysis of a Hungarian cohort. Orvosi Hetilap 145(10): 517-520, March 7, 2004

Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke. Postgraduate Medicine 128(6): 620-628, 2017

Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy. Thrombosis and Haemostasis 75(2): 219-223, 1996

Oral Anticoagulant Therapy at Elderly Age: Heart Failure and Nonvalvular Atrial Fibrillation. American Journal of Geriatric Cardiology 5(1): 78-83, 1996

Recurrent cerebral embolism and impending detachment of a previous nonmobile left atrial thrombus following initiation of anticoagulant therapy in a patient with nonvalvular atrial fibrillation. Echocardiography 18(6): 527-529, 2001

Very low-intensity anticoagulant therapy in elderly cardioembolic stroke patients with nonvalvular atrial fibrillation. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 31(9): 711-715, 1994

Late recurrence of embolic stroke after discontinuation of anticoagulant therapy in nonvalvular atrial fibrillation. Journal of Neurology 235(8): 499-500, 1988

Healthcare resources and needs in anticoagulant therapy for patients with nonvalvular atrial fibrillation. SAMOA Study. Revista Clinica Espanola 217(4): 193-200, 2017

Predictors of anticoagulant treatment in patients with nonvalvular atrial fibrillation: results from atrial fibrillation in Turkey: epidemiologic registry. Clinical and Applied Thrombosis/Hemostasis 21(2): 144-148, 2016

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation. Acc Current Journal Review 14(2): 59-0, 2005

The role of anticoagulant therapy in hemorrhagic transformation of acute ischaemic stroke in nonvalvular atrial fibrillation patients. European Journal of Neurology 26(2): E24-E24, 2019